U.S. flag

An official website of the United States government

NM_000312.4(PROC):c.574AAG[1] (p.Lys193del) AND not specified

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Nov 3, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003479063.1

Allele description [Variation Report for NM_000312.4(PROC):c.574AAG[1] (p.Lys193del)]

NM_000312.4(PROC):c.574AAG[1] (p.Lys193del)

Gene:
PROC:protein C, inactivator of coagulation factors Va and VIIIa [Gene - OMIM - HGNC]
Variant type:
Microsatellite
Cytogenetic location:
2q14.3
Genomic location:
Preferred name:
NM_000312.4(PROC):c.574AAG[1] (p.Lys193del)
HGVS:
  • NC_000002.12:g.127426123AAG[1]
  • NG_016323.1:g.12704AAG[1]
  • NM_000312.4:c.574AAG[1]MANE SELECT
  • NM_001375602.1:c.757AAG[1]
  • NM_001375603.1:c.739AAG[1]
  • NM_001375604.1:c.637AAG[1]
  • NM_001375605.1:c.676AAG[1]
  • NM_001375606.1:c.742AAG[1]
  • NM_001375607.1:c.760AAG[1]
  • NM_001375608.1:c.517AAG[1]
  • NM_001375609.1:c.550AAG[1]
  • NM_001375610.1:c.568AAG[1]
  • NM_001375611.1:c.574AAG[1]
  • NM_001375613.1:c.574AAG[1]
  • NP_000303.1:p.Lys193del
  • NP_001362531.1:p.Lys254del
  • NP_001362532.1:p.Lys248del
  • NP_001362533.1:p.Lys214del
  • NP_001362534.1:p.Lys227del
  • NP_001362535.1:p.Lys249del
  • NP_001362536.1:p.Lys255del
  • NP_001362537.1:p.Lys174del
  • NP_001362538.1:p.Lys185del
  • NP_001362539.1:p.Lys191del
  • NP_001362540.1:p.Lys193del
  • NP_001362542.1:p.Lys193del
  • LRG_599t1:c.577_579del
  • LRG_599:g.12704AAG[1]
  • NC_000002.11:g.128183697_128183699del
  • NC_000002.11:g.128183699AAG[1]
  • NM_000312.3:c.577_579del
  • NM_000312.3:c.577_579delAAG
  • NM_000312.4:c.577_579delAAGMANE SELECT
Protein change:
K174del
Links:
dbSNP: rs199469469
NCBI 1000 Genomes Browser:
rs199469469
Molecular consequence:
  • NM_000312.4:c.574AAG[1] - inframe_deletion - [Sequence Ontology: SO:0001822]
  • NM_001375602.1:c.757AAG[1] - inframe_deletion - [Sequence Ontology: SO:0001822]
  • NM_001375603.1:c.739AAG[1] - inframe_deletion - [Sequence Ontology: SO:0001822]
  • NM_001375604.1:c.637AAG[1] - inframe_deletion - [Sequence Ontology: SO:0001822]
  • NM_001375605.1:c.676AAG[1] - inframe_deletion - [Sequence Ontology: SO:0001822]
  • NM_001375606.1:c.742AAG[1] - inframe_deletion - [Sequence Ontology: SO:0001822]
  • NM_001375607.1:c.760AAG[1] - inframe_deletion - [Sequence Ontology: SO:0001822]
  • NM_001375608.1:c.517AAG[1] - inframe_deletion - [Sequence Ontology: SO:0001822]
  • NM_001375609.1:c.550AAG[1] - inframe_deletion - [Sequence Ontology: SO:0001822]
  • NM_001375610.1:c.568AAG[1] - inframe_deletion - [Sequence Ontology: SO:0001822]
  • NM_001375611.1:c.574AAG[1] - inframe_deletion - [Sequence Ontology: SO:0001822]
  • NM_001375613.1:c.574AAG[1] - inframe_deletion - [Sequence Ontology: SO:0001822]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004223000Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Uncertain significance
(Nov 3, 2023)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Expression and functional characterisation of natural R147W and K150del variants of protein C in the Chinese population.

Ding Q, Yang L, Hassanian SM, Rezaie AR.

Thromb Haemost. 2013 Apr;109(4):614-24. doi: 10.1160/TH12-10-0760. Epub 2013 Feb 7.

PubMed [citation]
PMID:
23389250
PMCID:
PMC3634890

Supplementary research on K150del variant of activated protein C.

Lin WY, Tang L, Lu X, Hu Y.

Aging (Albany NY). 2021 Apr 25;13(9):12466-12478. doi: 10.18632/aging.202904. Epub 2021 Apr 25. Erratum in: Aging (Albany NY). 2021 Aug 13;13(15):19945. doi: 10.18632/aging.203437.

PubMed [citation]
PMID:
33896796
PMCID:
PMC8148483
See all PubMed Citations (4)

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV004223000.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)

Description

Variant summary: PROC c.577_579delAAG (p.Lys193del) results in an in-frame deletion that is predicted to remove one amino acid from the encoded protein. The variant allele was found at a frequency of 0.0007 in 251380 control chromosomes, predominantly at a frequency of 0.0096 within the East Asian subpopulation in the gnomAD database, including 1 homozygote. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance, although this frequency is not suggestive of a variant associated with highly penetrant Mendelian disease. c.577_579delAAG has been reported in the literature as a risk factor for venous thrombosis and ischemic stroke, without a clear pattern of Mendelian inheritance, predominantly in individuals of East Asian descent (e.g., Tang_2012, Lu_2013). Several publications report experimental evidence evaluating an impact on protein function, finding that the variant results in a moderate reduction in anticoagulant activity relative to wild-type as well as a distinct transcriptional profile in HEK 293T cells (e.g., Tang_2012, Ding_2013, Lin_2021). The following publications have been ascertained in the context of this evaluation (PMID: 23389250, 33896796, 22976599, 22817391). Three submitters have reported clinical-significance assessments for this variant to ClinVar after 2014, citing the variant as uncertain significance (n = 2) and pathogenic (n = 1). Based on the evidence outlined above, the variant likely represents a risk allele for venous thrombosis and ischemic stroke and was therefore classified as VUS-possibly pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jun 9, 2024